Resibufogenin
CAS No. 465-39-4
Resibufogenin ( RBG; Bufotenine; Resibufogenin )
产品货号. M18571 CAS No. 465-39-4
Resibufogenin is a cytotoxic steroid isolated from the Chinese drug ChanSu. Resibufogenin can inhibit rectifier potassium current ( I K ) and transient potassium current ( I A ), it has pathological effects on central nervous system.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥745 | 有现货 |
|
5MG | ¥1150 | 有现货 |
|
10MG | ¥1798 | 有现货 |
|
25MG | ¥3629 | 有现货 |
|
50MG | ¥5484 | 有现货 |
|
100MG | ¥7800 | 有现货 |
|
500MG | ¥15633 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Resibufogenin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Resibufogenin is a cytotoxic steroid isolated from the Chinese drug ChanSu. Resibufogenin can inhibit rectifier potassium current ( I K ) and transient potassium current ( I A ), it has pathological effects on central nervous system.
-
产品描述Resibufogenin is a cytotoxic steroid isolated from the Chinese drug ChanSu. Resibufogenin can inhibit rectifier potassium current ( I K ) and transient potassium current ( I A ), it has pathological effects on central nervous system. Resibufogenin corrects hypertension in a rat model of human preeclampsia, it not only prevents the advent of hypertension and proteinuria, but also the development of intrauterine growth restriction. Resibufogenina's major metabolic pathway in the human liver is CYP3A4 dominantly mediated 5β-hydroxylation .
-
同义词RBG; Bufotenine; Resibufogenin
-
通路Angiogenesis
-
靶点PDE
-
受体Others
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number465-39-4
-
分子量384.51
-
分子式C24H32O4
-
纯度98%
-
溶解度DMSO : 100 mg/mL 260.07 mM;
-
SMILESCC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C6=COC(=O)C=C6)C)O
-
化学全称14,15beta-Epoxy-3beta-hydroxy-5beta-bufa-20,22-dienolide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
ITI214 free base
ITI-214 is a potent, selective phosphodiesterase 1 (PDE1) inhibitor with Ki of 58 pM.
-
CI-1044
CI-1044 is a potent, selective and orally bioavailable PDE4 inhibitor with IC50 of 0.27 uM.
-
Vardenafil hydrochlo...
Vardenafil hydrochloride is a New Phosphodiesterase Type 5(PDE5) Inhibitor in the Treatment of Erectile Dysfunction in Men With Diabetes.